Annual report pursuant to Section 13 and 15(d)

Investment in Equity Securities

v3.10.0.1
Investment in Equity Securities
12 Months Ended
Sep. 30, 2018
Investments, Debt and Equity Securities [Abstract]  
Investment in Equity Securities

NOTE 5 - INVESTMENT IN EQUITY SECURITIES

 

As of September 30, 2018 the Company held one million (1,000,000) common stock of Amarantus BioScience Holdings, Inc. (AMBS) with a fair value of $33,800.